Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · January 28, 2023

Efficacy and Safety of Velusetrag in Patients With Diabetic or Idiopathic Gastroparesis

Neurogastroenterology and Motility


Additional Info

Neurogastroenterology and Motility
A randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis
Neurogastroenterol. Motil. 2023 Jan 09;[EPub Ahead of Print], TL Abell, B Kuo, T Esfandyari, ND Pfeifer, M Grimaldi, C Renzulli, R Tacchi, K Zhou, CN Barnes, DD Nguyen, L Nguyen, NJ Talley, R McCallum

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading